Prenylation-defective human connexin32 mutants are normally localized and function equivalently to wild-type connexin32 in myelinating schwann cells

Journal of Neuroscience

Volumn 25, Issue 31, 2005, Pages 7111-7120

  Huang, Yan ^a   Sirkowski, Erich E ^a   Stickney, John T ^b   Scherer, Steven S ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

CMT; Cx32; Gap junction; Myelin; Neuropathy; X linked Charcot Marie Tooth disease

Indexed keywords

CONNEXIN 32; MEVALONOLACTONE; MYELIN; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN COS7; CONTROLLED STUDY; GAP JUNCTION; GENE; GENE MUTATION; GJB1 GENE; HEREDITARY MOTOR SENSORY NEUROPATHY; MALE; MOUSE; MYELINATED NERVE; MYELINATION; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PHENOTYPE; PRENYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN TRANSPORT; SCHWANN CELL; TRANSGENE; TRANSGENIC MOUSE; X CHROMOSOME LINKED DISORDER;

AMINO ACID MOTIFS; ANIMALS; CODON, TERMINATOR; CONNEXINS; CONSERVED SEQUENCE; CYSTEINE; DNA; EVOLUTION, MOLECULAR; FEMALE; FEMORAL NERVE; GLYCINE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MUTATION; MYELIN SHEATH; PHENOTYPE; PROTEIN ISOPRENYLATION; SCHWANN CELLS; SCIATIC NERVE; SERINE; TISSUE DISTRIBUTION;

EID: 23444439370     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1319-05.2005     Document Type: Article

References (66)

1. Abel A, Bone LJ, Messing A, Scherer SS, Fischbeck KH (1999) Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J Neuropathol Exp Neurol 58:702-710.
2. Abrams CK, Oh S, Ri Y, Bargiello TA (2000) Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res Rev 32:203-214.
3. Abrams CK, Freidin MM, Verselis VK, Bennett MVL, Bargiello TA (2001) Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease. Brain Res 900:9-25.
4. Abrams CK, Freidin M, Bukauskas F, Dobrenis K, Bargiello TA, Verselis VK, Bennett MVL, Chen L, Sahenk Z (2003) Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32. J Neurosci 23:10548-10558.
5. Altevogt BM, Kleopa KA, Postma FR, Scherer SS, Paul DL (2002) Cx29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci 22:6458-6470.
6. Anzini P, Neuberg DH-H, Schachner M, Nelles E, Willecke K, Zielasek J, Toyka K, Suter U, Martini R (1997) Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin32. J Neurosci 17:4545-4561.
7. Arroyo EJ, Xu Y-T, Zhou L, Messing A, Peles E, Chiu SY, Scherer SS (1999) Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvb2, and Caspr. J Neurocytol 28:333-347.
8. Balice-Gordon RJ, Bone LJ, Scherer SS (1998) Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol 142:1095-1104.
9. Bergoffen J, Scherer SS, Wang S, Oronzi-Scott M, Bone L, Paul DL, Chen K, Lensch MW, Chance P, Fischbeck K (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262:2039-2042.
10. Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813-823.
11. Bordier BB, Glenn JS (2004) Testing antivirals against hepatitis delta virus: farnesyl transferase inhibitors. Methods Mol Med 96:539-553.
12. Boyd IA, Davey MR (1968) Composition of peripheral nerves. Edinburgh: Livingstone.
13. Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD (1985) Factors affecting the efficiency of introducing foreign genes into mice by microinjecting eggs. Proc Natl Acad Sci USA 82:4438-4442.
14. Bruzzone R, White TW, Paul DL (1996) Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238:1-27.
15. Casey PJ (1994) Lipid modifications of G proteins. Curr Opin Cell Biol 6:219-225.
16. Castro C, Gomez-Hernandez JM, Silander K, Barrio LC (1999) Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J Neurosci 19:3752-3760.
17. Chandross KJ, Kessler JA, Cohen RI, Simburger E, Spray DC, Bieri P, Dermietzel R (1996) Altered connexin expression after peripheral nerve injury. Mol Cell Neurosci 7:501-518.
18. Choi BO, Lee MS, Shin SH, Hwang JH, Choi KG, Kim WK, Sunwoo IN, Kim NK, Chung KW (2004) Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum Mutat 24:185-186.
19. Fannon AM, Sherman DL, Ilyina-Gragerova G, Brophy PJ, Friedrich VL, Colman DR (1995) Novel E-cadherin mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. JCB 129:189-202.
20. Fivaz M, Meyer T (2003) Specific localization and timing in neuronal signal transduction mediated by protein-lipid interactions. Neuron 40:319-330.
21. Glenn JS, Watson JA, Havel CM, White JM (1992) Identification of a prenylation site in delta virus large antigen. Science 256:1331-1333.
22. Hahn AF, Brown WF, Koopman WJ, Feasby TE (1990) X-linked dominant hereditary motor and sensory neuropathy. Brain 113:1511-1525.
23. Hancock JF, Magee AI, Childs JE, Marshall CJ (1989) All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57:1167-1177.
24. Hayes JS, Lawler OA, Walsh MT, Kinsella BT (1999) The prostacyclin receptor is isoprenylated. Isoprenylation is required for efficient receptor-effector coupling. J Biol Chem 274:23707-23718.
25. Iniguez-Lluhi JA, Simon MI, Robishaw JD, Gilman AG (1992) G protein beta gamma subunits synthesized in Sf9 cells. Functional characterization and the significance of prenylation of gamma. J Biol Chem 267:23409-23417.
26. Ionasescu V, Ionasescu R, Searby C (1996) Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am J Med Genet 63:486-491.
27. Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE, Der CJ (1990) Farnesol modification of Kirsten- ras exon 4B protein is essential for transformation. Proc Natl Acad Sci USA 87:3042-3046.
28. James GL, Goldstein JL, Brown MS, Rawson TE, Somers TC, McDowell RS, Crowley CW, Lucas BK, Levinson AD, Marsters JC Jr (1993) Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 260:1937-1942.
29. Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE, Der CJ (1992) Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci USA 89:6403-6407.
30. Kisselev O, Ermolaeva M, Gautam N (1995) Efficient interaction with a receptor requires a specific type of prenyl group on the G protein gamma subunit. J Biol Chem 270:25356-25358.
31. Kobari M, Irie J, Takizawa K, Yoshihara T, Sobue G (2000) X-linked Charcot-Marie-Tooth disease with a new mutation (Thr191Ala) in the connexin32. Rinsho Shinkeigaku 40:896-899.
32. Kumar NM, Friend DS, Gilula NB (1995) Synthesis and assembly of human b1 gap junctions in BHK cells by DNA transfection with the human b1 cDNA. J Cell Sci 108:3725-3734.
33. Kuroda Y, Suzuki N, Kataoka T (1993) The effect of posttranslational modifications on the interaction of Ras2 with adenylyl cyclase. Science 259:683-686.
34. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, Metzger D, Macklin WB, Chambon P, Suter U (2003) Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci 22:430-440.
35. Li J, Hertzberg EL, Nagy JI (1997) Connexin32 in oligodendrocytes and association with myelinated fibers in mouse and rat brain. J Comp Neurol 379:571-591.
36. Li X, Lynn BD, Olson C, Meier C, Davidson KGV, Yasumura T, Rash JE, Nagy JL (2002) Connexin29 expression, immunocytochemistry and freeze-fracture replica immunogold labelling (FRIL) in sciatic nerve. Eur J Neurosci 16:795-806.
37. Liang GS, de Miguel M, Gomez-Hernandez JM, Glass JD, Scherer SS, Mintz M, Barrio LC, Fischbeck KH (2005) Severe neuropathy with leaky connexin32 hemichannels. Ann Neurol 57:749-754.
38. Lin GS, Glass JD, Shumas S, Scherer SS, Fischbeck KH (1999) A unique mutation in connexin32 associated with severe, early onset CMTX in a heterozygous female. Ann NY Acad Sci 883:481-485.
39. Lupski JR, Garcia CA (2001) Charcot-Marie-Tooth peripheral neuropathies and related disorders. In: The metabolic and molecular basis of inherited disease, Ed 8 (Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, eds), pp 5759-5788. New York: McGraw-Hill.
40. Meggouh F, Benomar A, Rouger H, Tardieu S, Birouk N, Tassin J, Barhoumi C, Yahyaoui M, Chkili T, Brice A, Le Guern E (1998) The first de novo mutation of the connexin 32 gene associated with X linked Charcot-Marie-Tooth disease. J Med Genet 35:251-252.
41. Meier C, Dermietzel R, Davidson KGV, Yasumura T, Rash JE (2004) Connexin32-containing gap junctions in Schwann cells at the internodal zone of partial myelin compaction and in Schmidt-Lanterman incisures. J Neurosci 24:3186-3198.
42. Miyamoto T, Morita K, Takemoto D, Takeuchi K, Kitano Y, Miyakawa T, Nakayama K, Okamura Y, Sasaki H, Miyachi Y, Furuse M, Tsukita S (2005) Tight junctions in Schwann cells of peripheral myelinated axons: a lesson from claudin-19-deficient mice. J Cell Biol 169:527-538.
43. Musil LS, Goodenough DA (1993) Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell 74:1075-1077.
44. Nelles E, Butzler C, Jung D, Temme A, Gabriel H-D, Dahl U, Traub O, Stumpel F, Jungermann K, Zielasek J, Toyka KV, Dermietzel R, Willecke K (1996) Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci USA 93:9565-9570.
45. Neuhaus IM, Dahl G, Werner R (1995) Use of alternative promoters for tissue-specific expression of the gene coding for connexin32. Gene 158:257-262.
46. Neuhaus IM, Bone L, Wang S, Ionasescu V, Werner R (1996) The human connexin32 gene is transcribed from two tissue-specific promoters. Biosci Rep 16:239-248.
47. Oh S, Ri Y, Bennett MVL, Trexler EB, Verselis VK, Bargiello TA (1997) Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron 19:927-938.
48. Pedraza L, Owens GC, Green LAD, Salzer JL (1990) The myelin-associated glycoproteins: membrane disposition, evidence of a novel disulfide linkage between immunoglobulin-like domains, and posttranslational palmitylation. J Cell Biol 111:2651-2661.
49. Pot C, Simonen M, Weinmann O, Schnell L, Christ F, Stoeckle S, Berger P, Rulicke T, Suter U, Schwab ME (2002) Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol 159:29-35.
50. Scherer SS, Deschênes SM, Xu Y-T, Grinspan JB, Fischbeck KH, Paul DL (1995) Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 15:8281-8294.
51. Scherer SS, Xu Y-T, Nelles E, Fischbeck K, Willecke K, Bone LJ (1998) Connexin32-null mice develop a demyelinating peripheral neuropathy. Glia 24:8-20.
52. Scherer SS, Arroyo EJ, Peles E (2004) Functional organization of the nodes of Ranvier. In: Myelin biology and disorders (Lazzarini RA, ed), pp 89-116. San Diego: Elsevier.
53. Scherer SS, Xu Y-T, Messing A, Willecke K, Fischbeck KH, Bone Jeng LJ (2005) Transgenic expression of human Connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. J Neurosci 25:1550-1559.
54. Seabra MC, Ho YK, Anant JS (1995) Deficient geranylgeranylation of Ram/ Rab27 in choroideremia. J Biol Chem 270:24420-24427.
55. Sepp-Lorenzino L, Coleman PS, Larocca JN (1994) Isoprenylated proteins in myelin. J Neurochem 62:1539-1545.
56. Shy ME, Lupski JR, Chance PF, Klein CJ, Dyck PJ (2005) Hereditary motor and sensory neuropathies: an overview of clinical, genetic, electrophysiologic, and pathologic features. In: Peripheral neuropathy (Dyck PJ, Thomas PK, eds), pp 1623-1658. Philadelphia: Elsevier.
57. Silander K, Meretoja P, Juvonen V, Ignatius J, Pihko H, Saarinen A, Wallden T, Herrgard E, Aula P, Savontaus ML (1998) Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat 12:59-68.
58. Sillen A, Anneren G, Dahl N (1998) A novel mutation (C201R) in the transmembrane domain of connexin32 in severe X-linked Charcot-Marie-Tooth disease. Hum Mutat Suppl 1:S8-S9.
59. Söhl G, Gillen C, Bosse F, Gleichmann M, Muller HW, Willecke K (1996) A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur J Cell Biol 69:267-275.
60. Sung C-H, Makino C, Baylor D, Nathans J (1994) A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment. J Neurosci 14:5818-5833.
61. Swett JE, Wikohm RP, Blanks RHI, Swett AL, Conley LC (1986) Motoneurons of the rat sciatic nerve. Exp Neurol 93:227-252.
62. Trapp BD, Andrews SB, Wong A, O'Connell M, Griffin JW (1989) Colocalization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibers. J Neurocytol 18:47-60.
63. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Sohl G (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 383:725-737.
64. Wrabetz L, Feltri ML, Kleopa KA, Scherer SS (2004) Inherited neuropathies: clinical, genetic, and biological features. In: Myelin biology and disorders (Lazzarini RA, ed), pp 905-951. San Diego: Elsevier.
65. Yum SW, Kleopa KA, Shumas S, Scherer SS (2002) Diverse trafficking abnormalities for connexin32 mutants causing CMTX. Neurobiol Dis 11:43-52.
66. Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241-269.